Promethos Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Promethos Capital’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	+14,980	New	+$202K	0.06%	54
2025 Q1	–	Sell	-677,184	Closed	-$10.7M	–	88
2024 Q4	$10.7M	Buy	677,184 +3,514	+0.5%	+$52.8K	3.77%	6
2024 Q3	$10.7M	Hold	673,670	–	–	3.81%	6
2024 Q2	$10.2M	Buy	673,670 +85,250	+14%	+$1.22M	3.87%	7
2024 Q1	$8.63M	Buy	588,420 +48,385	+9%	+$706K	5.07%	6
2023 Q4	$7.52M	Buy	+540,035	New	+$7.22M	5.45%	6

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Promethos Capital's RDY Position: Q2 2026 in Review

Promethos Capital opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 14,980 shares worth $217K. The stake represents 0.06% of the portfolio and ranks #54 among its holdings. This is a return to the name: Promethos Capital previously reported a position in RDY as recently as Q4 2024.

Promethos Capital first reported a position in RDY in Q4 2023 and has held it in 6 quarters since. The position peaked at $10.7M in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Promethos Capital held 14,980 shares of Dr. Reddy's Laboratories worth $217K as of Q2 2026.
Dr. Reddy's Laboratories was a new Promethos Capital position in Q2 2026.
Dr. Reddy's Laboratories made up 0.06% of Promethos Capital's portfolio in Q2 2026, its #54 holding.
Promethos Capital first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 6 quarters since.
Promethos Capital's Dr. Reddy's Laboratories position peaked at $10.7M in Q3 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Promethos Capital's 13F filing for Q2 2026, filed 12 Aug 2026.